Rapacuronium bromide

Drug Profile

Rapacuronium bromide

Alternative Names: ORG 9487; Raplon

Latest Information Update: 18 Apr 2001

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Organon Teknika
  • Class Androstanols; Muscle relaxants
  • Mechanism of Action Neuromuscular blocking agents
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Market Withdrawal Muscle hypertonia

Most Recent Events

  • 18 Apr 2001 Discontinued-preregistration for Hypertonia in Europe (IV)
  • 05 Apr 2001 Withdrawn for Hypertonia in USA (IV)
  • 16 Feb 2001 A study in paediatric patients has been added to the Muscular Disorders therapeutic trials section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top